{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:39:26Z","timestamp":1791085166364,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.clim.2023.109242","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T05:38:43Z","timestamp":1674884323000},"page":"109242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Long-term data on efficacy and safety of adalimumab in Beh\u00e7et's disease"],"prefix":"10.1016","volume":"247","author":[{"given":"T.B.","family":"van der Houwen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Humer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.O.","family":"Missotten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.H.J.","family":"Thiadens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.clim.2023.109242_bb0005","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et\u2019s disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109242_bb0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2016.12.001","article-title":"An elevated pro-inflammatory cytokines profile in Behcet\u2019s disease: a multiplex analysis","volume":"186","author":"Gholijani","year":"2017","journal-title":"Immunol. Lett."},{"issue":"9","key":"10.1016\/j.clim.2023.109242_bb0015","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00417-015-3016-0","article-title":"Serum omentin, resistin and tumour necrosis factor-\u03b1 levels in Behcet patients with and without ocular involvement","volume":"253","author":"T\u00fcrkc\u00fc","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.clim.2023.109242_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/jir.2018.0116","article-title":"Role of serum miR-181b, Proinflammatory cytokine, and adhesion molecules in Beh\u00e7et\u2019s disease","volume":"39","author":"El Boghdady","year":"2019","journal-title":"J. Interf. Cytokine Res."},{"issue":"4","key":"10.1016\/j.clim.2023.109242_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/ar2784","article-title":"Cytokines in the colon of a patient with Beh\u00e7et\u2019s disease","volume":"11","author":"Kappen","year":"2009","journal-title":"Arthritis Res Ther."},{"issue":"6","key":"10.1016\/j.clim.2023.109242_bb0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03009740600905380","article-title":"Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet\u2019s disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD","volume":"35","author":"Dalghous","year":"2006","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2023.109242_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00296-003-0400-6","article-title":"Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Beh\u00e7et\u2019s disease","volume":"25","author":"D\u00fczg\u00fcn","year":"2005","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.clim.2023.109242_bb0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/03009740701747137","article-title":"Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Beh\u00e7et\u2019s disease","volume":"37","author":"Turan","year":"2008","journal-title":"Scand. J. Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2023.109242_bb0045","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archophthalmol.2011.2698","article-title":"Multicenter study of infliximab for refractory uveoretinitis in Beh\u00e7et disease","volume":"130","author":"Okada","year":"2012","journal-title":"Arch Ophthalmol (Chicago, Ill 1960)"},{"issue":"6","key":"10.1016\/j.clim.2023.109242_bb0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/09273948.2013.779727","article-title":"Long-term clinical outcomes in patients with refractory uveitis associated with Beh\u00e7et disease treated with infliximab","volume":"21","author":"Al Rashidi","year":"2013","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"4","key":"10.1016\/j.clim.2023.109242_bb0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.2006.064279","article-title":"Adalimumab: a new modality for Beh\u00e7et\u2019s disease?","volume":"66","author":"van Laar","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.clim.2023.109242_bb0060","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10050","key":"10.1016\/j.clim.2023.109242_bb0065","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet."},{"issue":"8697","key":"10.1016\/j.clim.2023.109242_bb0070","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's Disease","volume":"335","year":"1990","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.clim.2023.109242_bb0075","series-title":"Disease IS for B. Behcet\u2019s Disease Current Activity Form 2006","year":"2006"},{"issue":"4","key":"10.1016\/j.clim.2023.109242_bb0080","first-page":"S58","article-title":"Adalimumab for treatment of severe Beh\u00e7et\u2019s uveitis: a retrospective long-term follow-up study","volume":"32","author":"Interlandi","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2023.109242_bb0085","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10067-016-3417-4","article-title":"Adalimumab effectiveness in Beh\u00e7et\u2019s disease: short and long-term data from a multicenter retrospective observational study","volume":"36","author":"Vitale","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2023.109242_bb0090","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/bjophthalmol-2017-310733","article-title":"Cumulative retention rate of adalimumab in patients with Beh\u00e7et\u2019s disease-related uveitis: a four-year follow-up study","volume":"102","author":"Fabiani","year":"2018","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.clim.2023.109242_bb0095","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.24709","article-title":"Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms","volume":"60","author":"Bartelds","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.clim.2023.109242_bb0100","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/ard.2006.065615","article-title":"Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis","volume":"66","author":"Bartelds","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.clim.2023.109242_bb0105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3109\/00365521.2016.1157894","article-title":"Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn\u2019s disease","volume":"51","author":"Bodini","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.clim.2023.109242_bb0110","first-page":"43","article-title":"Adalimumab provides long-lasting clinical improvement in refractory mucocutaneous Beh\u00e7et\u2019s disease without formation of antidrug antibodies","volume":"37","author":"Verboom","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"10.1016\/j.clim.2023.109242_bb0115","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/art.40235","article-title":"Brief report: drug-free long-term remission in severe Beh\u00e7et\u2019s disease following withdrawal of successful anti-tumor necrosis factor treatment","volume":"69","author":"Sfikakis","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"9","key":"10.1016\/j.clim.2023.109242_bb0120","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ophtha.2018.02.020","article-title":"Successful optimization of adalimumab therapy in refractory uveitis due to Beh\u00e7et\u2019s disease","volume":"125","author":"Mart\u00edn-Varillas","year":"2018","journal-title":"Ophthalmology."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623000219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623000219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T04:06:26Z","timestamp":1738901186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623000219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":24,"alternative-id":["S1521661623000219"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109242","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term data on efficacy and safety of adalimumab in Beh\u00e7et's disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109242"}}